A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France.
Kaspar NielandAntoine LabbéCedric SchweitzerGaetan GicquelJoris KleintjensAmrita OstawalMaarten TreurHeather FalveyPublished in: PloS one (2021)
Results demonstrate that iStent inject TBS + Cat Sx is a cost-effective intervention for intraocular pressure reduction when compared to Cat Sx alone in France.